James L. Tyree - 04 Aug 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Aug 2022
Net transactions value
-$502,200
Form type
4
Filing time
08 Aug 2022, 19:27:05 UTC
Previous filing
13 Jun 2022
Next filing
24 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Sale $502,200 -10,000 -52% $50.22 9,138 04 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.